Mezlocillin pharmacokinetics in patients with normal and impaired renal functions.
The pharmacokinetics of intravenous bolus doses of 1.0 g of mezlocillin were studied in 13 persons with normal and reduced renal functions. In renal failure a moderate increase was observed for the terminal serum half-life(t1/2 beta). This changed from a mean of 1.1 h at a glomerular filtration rate...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1979
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352923/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/526008/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.5.651 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|